PEOPLE - Australian National Health and Medical Research Council makes appointment:
This article was originally published in Clinica
Executive Summary
Australia's National Health and Medical Research Council (NHMRC) has appointed Warwick Anderson as CEO, effective from June 7. Over a five-year term ending 2011, Professor Anderson, a senior healthcare research and management expert, will focus on how best to invest in social and commercial applications of health and medical research. He will also strengthen the council's operational division to ensure continued expert advice on health issues to the government after the council becomes independent, on July 1.
You may also be interested in...
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.